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To determine the role of integrins in mature osteoblasts in vivo, we expressed in transgenic mice a dominant-negative
integrin subunit (b1-DN) consisting of the b1 subunit cytoplasmic and transmembrane domains, driven by the osteoblast-
specific osteocalcin promoter. Immature osteoblasts isolated from transgenic animals differentiated normally in vitro until
the osteocalcin promoter became active; thereafter they detached from the substratum, suggesting that b1-DN was
mpairing adhesion in mature osteoblasts. Transgenic animals had reduced bone mass, with increased cortical porosity in
ong bones and thinner flat bones in the skull. At 35 days, the rate of bone formation was reduced in cortical bone, and the
arietal bones were 45% thinner than in wild-type animals. Active osteoblasts were less polar and had larger areas of
ytoplasm with intracellular stores of matrix molecules. Osteocyte lacunae appeared normal around the cell body but did
ot have normal canilicular structures. At 90 days, the parietal bone of transgenic males was of normal width, suggesting
hat the original defect in matrix deposition had been repaired or compensated for. In contrast, transgenic females still had
ecreased bone mass in the parietal bone at 90 days. The decreased bone mass in TG females was accompanied by increased
taining for osteoclast activity, suggesting that there was a sex-specific defect in mature animals. © 2000 Academic Press
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1INTRODUCTION
Bone is a highly dynamic tissue that is continually
repaired and remodeled in response to physiological and
environmental stimuli, such as systemic hormones and
mechanical strain. The formation and homeostasis of all
tissues require extensive interactions between specialized
cells and the extracellular matrix (ECM)1 (Damsky et al.,
997). Bone is a model tissue in which to study these types
f interactions, because it has a large and extensive ECM
hat is secreted and organized by a single cell type, the
steoblast. These cells, in turn, are a model for studying
ell–ECM interactions, because they have multiple com-
lex interactions with ECM that change as they differenti-
1 Abbreviations used: Col I, collagen type I; ECM, extracellular
matrix, FN, fibronectin; LN, laminin; MSC, marrow stromal cells;wTG, transgenic; WT, wild type.
2te from mature osteoblasts into osteocytes. It is not well
nderstood, however, how osteoblasts coordinate bone for-
ation or respond to external stimuli (e.g., mechanical
orces, systemic hormones) or how cell surface receptors are
nvolved in these processes.
Integrins are a major family of ECM receptors that
ransduce signals from the environment to the cell interior.
ignals from integrin ECM receptors can synergize with
ignals from growth factor receptors to regulate down-
tream cellular functions such as cytoskeletal organization,
ene expression, and apoptosis (Damsky and Werb, 1992;
iyamoto et al., 1996; Giancotti and Rouslahti, 1999).
steoblasts have a rich repertoire of integrin receptors
Clover et al., 1992; Gohel et al., 1995; Grzesik and Robey,
994; Hughes et al., 1993; Moursi et al., 1997; Saito et al.,
994). Using osteoblast cell culture systems (Bellows et al.,
986), we and others have shown that integrin interactions
ith fibronectin (FN) and collagen type I (Col I) are critical
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3Altered Integrin Function in Osteoblastsfor osteoblast differentiation (Gronowicz and Derome,
1994; Moursi et al., 1996, 1997) and survival (Globus et al.,
1998). Although primary cell systems are useful, they do
not represent a physiological environment, because they do
not accurately reproduce the three-dimensional structure of
bone matrix, and they are not subject to multiple factors
present in vivo (i.e., hormones, mechanical loading). To
better understand how integrin functions regulate osteo-
blast behavior in vivo, it is necessary to establish appropri-
ate genetic models.
Mutations in bone matrix molecules often result in
striking skeletal phenotypes, some of which are analogous
to human diseases such as osteogenesis imperfecta, osteo-
arthritis, and chondrodysplasia (Faessler et al., 1996). How-
ever, there are no known genetic models of defective
integrin function in bone formation, and therefore the
potential contribution of integrin receptors to skeletal dis-
eases is still unclear. Null mutations of individual integrin
subunit genes have not provided suitable models to study
integrin involvement in bone formation, either because
they result in embryonic lethality or because they have no
detectable bone phenotype (Brakebusch et al., 1997; Yang et
al., 1993). Integrins of the b1 family, for example, are
essential for normal development, and inactivation of the
b1 gene results in early embryonic death (Faessler and
Meyer, 1995; Stephens et al., 1995).
To overcome these limitations, we targeted the expres-
sion of a dominant-negative b1 integrin subunit (b1-DN) to
ature osteoblasts in vivo. Expression of single-subunit
himeras containing b integrin intracellular and transmem-
rane domains but lacking the extracellular domain can
unction in a dominant-negative fashion to inhibit endoge-
ous integrin function in cell adhesion, spreading, migra-
ion, and matrix assembly (Chen et al., 1994; Faraldo et al.,
998; LaFlamme et al., 1994; Lukashev et al., 1994;
milenov et al., 1994). Expression of b1-DN was controlled
y the osteocalcin promoter, which is expressed only in
ature osteoblasts and osteocytes (Baker et al., 1992;
ikuni-Takagaki et al., 1995) and has been successfully
sed to target transgene expression to skeletal structures in
ransgenic (TG) mice (Baker et al., 1992; Erlebacher and
erynck, 1996; Frenkel et al., 1997). TG animals, which
hus had altered integrin function in mature osteoblasts and
steocytes, had a primary defect characterized by reduced
one mass in cortical and flat bones. The rate of cortical
one formation was also reduced in TG animals, and the
one that was formed appeared more disorganized. Mature
ransgenic females had a secondary defect characterized by
ess bone mass in flat bones accompanied by increased
taining for osteoclasts.
MATERIALS AND METHODS
Plasmid Construction
HA-b1-DN contained 118 nucleotides of the preprolactin signal
sequence, including 18 nucleotides before the first ATG and 10 t
Copyright © 2000 by Academic Press. All rightnucleotides downstream of the signal peptidase cleavage site,
cloned in frame with the coding sequence for 9 amino acids of an
immunogenic peptide of hemagglutinin (HA-tag), YPYDVPDYA
(Hamel et al., 1992), followed by the coding sequence for the
C-terminal 83 amino acids of human b1 (including the cytoplasmic
ail and transmembrane domains). The transgene construct con-
ained 1.8 kb of the rat osteocalcin promoter, 640 nucleotides of the
abbit b-globin intron, HA-tagged b1-DN, and 627 nucleotides from
he human growth hormone poly(A) tail cloned into Bluescript and
anked by two unique restriction sites (Spe and NotI) (Fig. 1).
Transgenic Mice
DBA/2 3 C57BL/6 F1 (B6D2 F1) mice were used to generate TG
ice using standard techniques (Hogan et al., 1986). We injected
he transgene construct as a 2.4-kb fragment excised from pOC-
A-b1 with Spe and NotI and purified by Qiex Gel Extraction. TG
mice were identified by Southern blot analysis of the tail DNA
(Laird et al., 1991), using the b-globin intron fragment as a
hybridization probe. TG lines were established and maintained on
a B6D2 F1 background. Subsequent generations of TG mice were
identified by PCR analysis or by dot blots, using the b-globin intron
as a probe. Heterozygous TG mice were bred to generate homozy-
gous TG and wild-type (WT) mating pairs. These were subse-
quently bred for phenotype analysis.
RNA Analysis
RNA analysis was done as described (Erlebacher and Derynck,
1996), except that the 39 primer used was specific for the HA-b1
gene.
Histomorphometry and Histological Analysis
Sample preparation. For kinetic analysis of bone formation,
mice were injected subcutaneously with the fluorochromes calcein
(10 mg calcein/kg mouse) and tetracycline (25 mg tetracycline/kg
mouse). Mice that were sacrificed on day 35 were injected with
calcein on day 30 and tetracycline on day 34. Dissected femur and
calvarial bones were immediately fixed in 70% EtOH and stored at
4°C. All samples were postfixed for 48 h in 10% neutral-buffered
formalin and equilibrated into PBS for 48 h. For plastic-embedded
sections, the samples were transferred to Villanueva bone stain
(osteochrome stain; Polysciences, Inc., Niles, IL) for 48 h, dehy-
drated in graded ethanols, and embedded in methylmethacrylate.
For paraffin-embedded sections, the samples were decalcified for 2
weeks in a PBS solution containing 10% EDTA, equilibrated back
into PBS for 48 h, dehydrated with EtOH, and then embedded. All
immunocytochemistry was done using paraffin sections that were
postfixed with MeOH. Paraffin sections were 5 mm and plastic
sections 4.5 mm in thickness. Histomorphometric measurements
ere made using the Osteomeasure program from Osteometrics
Atlanta, GA).
Cortical bone measurements. Cortical bone measurements
ere made on cross sections of paraffin- or methylmethacrylate-
mbedded femurs taken approximately 4 mm from the growth
late. Porosity of the cortical bone was measured using Osteomea-
ure software by tracing the perimeter of the cortical bone within
ne field of a cross section viewed through the 203 objective.
orous areas within the traced perimeter were measured, and
ercentage porosity was determined as % porous 5 porous area/
otal area 3 100. Two fields from a single section were measured
s of reproduction in any form reserved.
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4 Zimmerman et al.for each animal, and the average porosity of these fields was
reported. Quantification was based on the analysis of cortical bone
from 11 TG and 6 WT animals. Measurements of trabecular area
and thickness were made on one section per animal viewed
through a 203 objective; n 5 9 for WT and 10 for TG animals. The
one formation rate (mm3/mm2/day) was determined by tracing
fluorochrome labels on the endosteal surface of cortical bone.
Measurements were made of three separate 203 fields on a single
section. One section was analyzed per animal; n 5 4 for both WT
and TG animals.
Parietal bone measurements. Embedded parietal bones were
sectioned parallel to the occipital suture at a distance of ;1 mm
from the suture. Sections were viewed through the 203 objective,
and width and lamellar organization were measured on the center
field in each section. The width of the parietal bone was deter-
mined by tracing the perimeter of the bone within the field and
calculating the average width over the field. One section was
analyzed per animal. Measurements of width at 35 days were made
by analyzing parietal bones from 10 TG females, 4 TG males, 7 WT
females, and 5 WT males and at 90 days from 4 WT females, 5 TG
females, 6 WT males, and 9 TG males. To quantify the percentage
of lamellar bone, the sections were viewed through polarized light
to visualize the birefringence pattern of the collagen matrix, and
the area of lamellar bone was determined as % lamellar 5 lamellar
area/total bone area 3 100. Quantification was based on the
analysis of 35-day parietal bones from 10 WT and 11 TG animals.
Mouse Marrow Stromal Cell Cultures
Bone marrow was extruded from the femurs and tibias of
35-day-old mice and plated in a-MEM containing 15% FCS (Leboy
et al., 1991). Bone marrow from the femurs and tibias of one animal
was pooled and plated into two six-well tissue culture wells. The
cells were incubated at 37°C in 5% CO2, and the medium was
replaced every 2–3 days until the cultures were nearly confluent. At
this time the cells were trypsinized and replated at a density of
1.25 3 104 cells/cm2/0.5 ml medium. The next day (day 1) the
edium was replaced with inducing medium (a-MEM containing
15% FCS, 200 mM ascorbate phosphate, b-glycerol phosphate, and
100 ng/ml bone morphogenic protein-2), which was subsequently
replaced every 3 days until the cultures were used for analysis.
Adenovirus Production
Adenoviruses were produced as previously described (Hardy et
al., 1997). To make an adenovirus expressing green fluorescent
protein (GFP) a 0.8-kb DNA fragment containing the GFP gene was
removed from pEGFP-1 (Clontech, Palo Alto, CA) and cloned into
the pADlox vector for production of recombinant adenovirus. To
make an adenovirus expressing GFP from the osteocalcin pro-
moter, the CMV promoter in the pADlox plasmid was replaced
with a 1.8-kb osteocalcin promoter.
Whole-Mount TRAP Staining
For whole-mount staining of osteoclasts with tartrate-resistant
alkaline phosphatase (TRAP), calvaria were prepared using a leu-
kocyte acid phosphatase kit (Sigma Chemical Co., St. Louis, MO)
with the coupling dye replaced by Fast red-violet LB (Sigma)
(Erlebacher et al., 1998). Calvaria were fixed for 10 min in 2%
paraformaldehyde and 0.8% glutaraldehyde, followed by overnight
fixation in 70% EtOH. Calvaria were postfixed in MeOH for 1 h to
Copyright © 2000 by Academic Press. All rightinhibit non-cell-associated TRAP staining. Similar results were
observed when alternative protocols for TRAP staining were used.
X-ray Analysis
Dissected calvaria were fixed in 70% EtOH at 4°C and radio-
graphs of the fixed calvaria were taken on a Faxitron Model 43805
N (Hewlett–Packard, Palo Alto, CA), using Kodak X-OMAT TL
film. All X-rays used for quantification or for comparison were
taken simultaneously, and exposure was for 30 s at 35 kVp.
Scanning Electron Microscopy
Bone samples were prepared for scanning electron microscopy
analysis as previously described (Boyde and Jones, 1996). Organic
matrix components were removed from the samples by treatment
with a solution of NaOCl with 7% available chlorine content for
approximately 1 week, and the samples were washed extensively
with ddH2O, before being prepared for analysis.
RESULTS
Generation of Transgenic Mice
A 2.4-kb transgenic construct (Fig. 1A) that included a
1.8-kb segment of the rat osteocalcin promoter (Baker et al.,
1992), a globin intron, the HA-b1 gene, and a human
polyadenylation site was used to generate TG mice (Erle-
bacher and Derynck, 1996). Five TG founder lines were
identified by Southern blotting (Fig. 1B) and PCR analysis of
genomic DNA (data not shown). The founder lines were
tested for expression of transgene mRNA by reverse
transcription-PCR (Fig. 1B). Two lines were followed for
more extensive histological analysis. The phenotype was
more severe in animals homozygous for the transgene,
suggesting that the level of expression of the transgene
affected the severity of the phenotype (data not shown).
Immunostaining using an anti-HA antibody (Fig. 2A)
showed that the b1-DN construct was expressed by osteo-
blasts (arrows) and osteocytes (arrowheads). Endogenous b1
was localized by immunocytochemistry to osteoblasts on
the bone surface and osteocytes within the bone matrix in
a similar manner in sections from WT and TG animals
(Figs. 2B and 2D). Hoechst staining was used to visualize
nuclei and showed that osteoblasts expressing the b1-DN
appeared healthy and nonapoptotic (Fig. 2C). There did not
appear to be any mineralized surfaces denuded of cells,
suggesting that mature osteoblasts had not detached from
the bone surface.
The Transgene Is Appropriately Expressed by
Mature Osteoblasts in Vitro, and Transgene
Expression Results in Defective Adhesion
Primary stromal cells cultured from bone marrow differ-
entiate into osteoblasts over a 2-week period when grown in
the presence of bone morphogenic protein-2. Cells isolated
from both WT and TG bone marrow stroma grew and
s of reproduction in any form reserved.
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5Altered Integrin Function in Osteoblastsdifferentiated normally over this time period. The majority
of cultured cells from both WT and TG animals were
osteoblastic and after 9 days in culture stained positively for
the early osteoblast differentiation marker, alkaline phos-
phatase (data not shown). To determine whether activity
from the osteocalcin promoter was high enough to use
marrow stromal cells (MSC) as a model to assess transgene
expression and function in vitro, we tested for the activity
f the osteocalcin promoter using GFP as a reporter gene.
T MSC were infected with a recombinant adenovirus
xpressing GFP from the osteocalcin promoter or, as a
ontrol, GFP from the CMV promoter. Our results indicate
hat the CMV promoter was equally active in nodular and
nternodular cells (Fig. 3A) in mature cultures (13 days after
lating). In contrast, the osteocalcin promoter was highly
ctive in osteoblasts within bone-like multilayered nod-
les, as assessed by GFP expression (Fig. 3B), and was much
ess active in osteoblasts that were in the internodular
reas. These results show that the osteocalcin promoter is
FIG. 1. (A) The transgenic construct contains a 1.8-kb fragment of
the osteocalcin promoter followed by a globin intron, the b1-DN
gene, and a poly(A) tail. The 2.4-kb construct is flanked by unique
restriction sites for Spe and NotI. (B) Five founder lines were
established and the transgene is expressed in bone. Five founder
lines were identified by Southern analysis. The star denotes a
common restriction fragment within the b1-DN gene; the band
beneath the bar is due to nonspecific background. The inset shows
the results of reverse transcriptase-PCR on total RNA extracted
from TG animals in the absence (2) or presence (1) of primers for
the b1-DN gene. The band of the appropriate size is indicated by an
rrow.ighly active in MSC in vitro, that osteocalcin is preferen-
Copyright © 2000 by Academic Press. All rightially expressed in mature osteoblasts within bone-like
odules, and that MSC cultures should provide some in-
ight into the expression and mechanism of function of the
b1-DN gene.
In TG cultures, the b1-DN protein was detected by IF
sing antibodies against the HA-tag (Fig. 3C). Double-
uorescence microscopy showed that at day 9, the cells that
ontained the highest level of osteocalcin promoter activ-
ty, as determined by GFP expression (Fig. 3D), also had the
rightest staining for the transgene product (compare Figs.
C and 3D). These results suggest that the b1-DN gene was
ppropriately regulated by the osteocalcin promoter in
itro. Osteoblasts expressing high levels of the transgene
ppeared healthy and not apoptotic (Fig. 3E) and for the first
everal days after the initiation of osteocalcin promoter
ctivity remained spread and attached to the substratum
Fig. 3D).
Several days after the initiation of osteocalcin promoter
ctivity, WT cultures remained in multilayered sheets
ttached to the culture dish (Fig. 4A). In contrast, most of
he cells in TG cultures, including all cells with strong
ctivity from the osteocalcin promoter, detached from the
ubstratum as a sheet and contracted into three-
imensional structures (Fig. 4B). After several additional
ays in culture, individual cells and small clusters of TG
ells detached from the contracted three-dimensional struc-
ure (Fig. 4C). When medium conditioned by TG cultures
as transferred to WT cultures, there was no effect on cell
ttachment or matrix organization (data not shown), sug-
esting that cell matrix contraction and cell detachment
ere intrinsic behaviors of the TG cells and were not
aused by secreted factors. Taken together these data sug-
est that b1-DN is highly expressed on the cell surface of
mature osteoblasts and that in vitro, the expression levels
are high enough to perturb endogenous integrin function
and interfere with cell adhesion.
TG Cortical Bone Is Porous and Has a Decreased
Rate of Bone Formation
Osteocalcin is a late marker for mature osteoblasts. In
mice, the osteocalcin promoter is not highly expressed until
1–2 days after birth, a time after which the initial skeletal
template has been patterned and formed but before the
collagen matrix has been extensively mineralized. Accord-
ingly, no change in the size or pattern of the skeleton was
observed in TG animals compared with WT animals (data
not shown).
To assess the integrity and structure of bone matrix, TG
and WT bones were analyzed histologically. The cortical
bone from 12-day WT animals had a smooth surface when
viewed in cross section (Fig. 5A(a)). In addition, the bone on
the interior was solid and contiguous and was not disrupted
by large porous areas (Fig. 5A(a)). In contrast, the cortical
bone of TG animals was highly porous and noncontiguous
on the interior and had an irregular noncylindrical shape on
the surface (Fig. 5A(b)). The percentage of bone that was
s of reproduction in any form reserved.
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6 Zimmerman et al.porous rather than solid bone matrix was analyzed quanti-
tatively (Fig. 5B). The cortical bone of TG animals was
160% more porous than WT bone (Fig. 5B), while the
average thickness of the cortical bone in TG animals was
similar to that of WT (data not shown). These data indicate
that TG bone has significantly less bone mass than WT
bone. In contrast, trabecular bone mass was normal in TG
animals as assessed by measuring bone volume and trabec-
ular thickness (data not shown).
The rate of bone formation was measured on the en-
dosteal surface of cortical bone at 35 days by tracing
fluorochrome labels. In WT animals the bone formation
rate was 8.4 mm3/mm2/day, whereas in TG animals it was
.25 mm3/mm2/day. Thus the rate of bone formation in TG
ortical bone was approximately 40% that of WT animals
P , 0.05, t test), and this decreased bone formation rate
ay account for the decreased bone mass observed in TG
nimals.
TG Parietal Bone Is Thinner and More
Disorganized
The flat bones of the skull are formed by intramembra-
nous rather than by endochondral bone formation. Thus,
unlike cortical bone they are formed de novo and not
within a cartilage template. To determine the effects of
b1-DN expression on intramembranous bone formation, we
analyzed histologically parietal bones, which are the largest
FIG. 2. b1-DN is expressed by TG osteoblasts and osteocytes. Cr
T (D) animals stained by IF with antibody against the HA-tag in
icroscopy showing Hoechst nuclear staining of the TG sect
hotomicrographs are shown at 2003 magnification.flat bones of the skull. Cross sections of parietal bones from E
Copyright © 2000 by Academic Press. All rightT and TG animals were analyzed for thickness and for the
rganization of the bone matrix.
The parietal bones of TG animals were thinner than
hose of WT (Fig. 6) and therefore had less bone mass. The
arietal bones of 35-day TG females were 30% thinner than
hose from 35-day WT females (Fig. 6A, compare (b) and (d)).
nterestingly, the difference was most striking between TG
ales and WT males (Fig. 6A, compare (a) and (c)). The
arietal bones of 35-day TG males were 45% thinner than
hose of WT (Fig. 6B). Females normally have thinner flat
ones than their male counterparts, so the net result of
hese differences was that in the TG animals the parietal
ones were effectively the same thickness in males and
emales (Fig. 6A, compare (c) and (d)). These observations
uggest that in the TG animals, bone formation was limited
y integrin function during the time of rapid bone forma-
ion that occurs during growth.
At 35 days, the skeleton is mature in WT animals, and
he period of rapid skeletal growth has just concluded; thus
he majority of bone matrix present should be in a mature
orm. Accordingly, in 35-day WT animals 66% of the
arietal bone was arranged in an ordered lamellar structure
hat was easily visualized through polarized light (Fig. 7).
owever, in TG animals of the same age, only 25% of the
arietal bone had a similar structure (Fig. 7). The remainder
f the bone matrix appeared disorganized and resembled
ess-mature woven bone, suggesting that in TG animals
ections through the parietal bones of 35-day TG (A, B, and C) and
N (A) or the extracellular domain of b1 (B and D).(C) Fluorescence
hown in (A). Arrows, osteoblasts; arrowheads, osteocytes; alloss s
b1-D
ion sCM maturation is either defective or delayed.
s of reproduction in any form reserved.
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7Altered Integrin Function in OsteoblastsIn TG Animals ECM Organization Is Abnormal
Most WT osteoblasts were polarized, with the nucleus
positioned at the end of the cell away from the bone surface
and the cytoplasm and secretory organelles located close to
the cell surface in contact with the bone matrix. In TG
FIG. 3. The osteocalcin promoter is active in mature bone-like n
MSC were previously infected with a recombinant adenovirus tha
promoter (B). Arrows in (A) indicate GFP-expressing cells in nodu
previously infected with a recombinant adenovirus that expresses
stained with Hoechst (E) and then fixed and stained by IF with anti
that cells expressing high levels of GFP from the osteocalcin prom
C). Cells expressing high levels of b1-DN have intact nuclei (E) an
1003 magnification. The photomicrographs in (C–E) are shown at
FIG. 4. TG osteoblast cultures have an adhesion defect in vitro. M
days after plating. (C) A cluster of detaching TG MSC previously
photomicrographs in (A) and (B) are shown at 1003 magnification; (C)
Copyright © 2000 by Academic Press. All rightnimals, mature osteoblasts often lacked this distinctive
ntracellular arrangement and resembled nonpolarized cells
Figs. 8A and 8B). TG osteoblasts also had larger intracellu-
ar regions that stained strongly for type 1 collagen (Figs. 8C
nd 8D) and laminin (LN) (data not shown). Quantitative
s, and b1-DN is expressed by primary osteoblasts in vitro. 13-day
presses GFP from the CMV promoter (A) or from the osteocalcin
) and internodular (IN) areas of the culture. Day 9 cultures were
from the osteocalcin promoter (D). GFP-expressing cultures were
s against the HA tag (C). Triple IF of the same field of cells shows
D) also express high levels of b1-DN expressed on the cell surface
not apoptotic. The photomicrographs in (A) and (B) are shown at
magnification.
cultures derived from WT (A) and TG (B) animals are shown at 16
ted with pOC-GFP is observed by fluorescence microscopy. Theodule
t ex
lar (N
GFP
bodie
oter (
d areSC
infecis shown at 3203 magnification.
s of reproduction in any form reserved.
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8 Zimmerman et al.measurements were made of the cell area that stained
positively for Col I. On average, TG osteoblasts had 40%
more cytoplasm containing strong staining for Col I com-
pared with WT cells, suggesting that TG osteoblasts either
made more Col I or were defective in its secretion (P ,
.0014, t test). These results indicate that TG osteoblasts
ave changes in morphology and matrix distribution, which
uggests that osteoblast function is altered as a result of
ransgene expression.
Osteocytes are terminally differentiated cells within the
one matrix that also express osteocalcin and potentially
ontribute to the changes in bone mass and organization
bserved in TG animals. Each osteocyte cell body resides in
lacuna within the bone matrix. Multiple filopodia extend
rom each cell body into canilicular protrusions from the
acuna. The ECM of WT osteocyte lacunae and the associ-
ted caniliculi stained positively for Col I (Fig. 8E, arrow-
eads). This matrix protein was also localized to lacunae
urrounding TG osteocytes (Fig. 8F, arrowheads). However,
FIG. 5. In TG animals cortical bone is highly porous and irregular.
(A) Cross sections of paraffin-embedded cortical bones from 12-day
WT (a) and TG (b) animals. The inner and outer surfaces of cortical
bone from TG animals (b) were highly irregular (arrows), compared
with cortical bone from WT animals (a), and the interior of the
cortex was highly porous. (B) Quantitative measurements of poros-
ity in cortical bone. The bars denote SEM. The differences between
WT (n 5 6) and TG (n 5 11) are statistically significant (P , 0.03,
t test).here was no Col I staining of the caniliculi of TG animals,
Copyright © 2000 by Academic Press. All rightuggesting that these structures were abnormal. A similar
ifference between TG and WT was seen in staining for LN
data not shown), suggesting that the defects in bone matrix
bserved in the TG animals were not specific for Col I. To
ry to determine whether normal filopodia were formed by
G osteocytes, we stained for the gap junction protein
onnexin 43, a known marker of osteocyte filopodia. Al-
hough cell bodies of both normal and TG osteocytes
tained positively for connexin 43 (data not shown), the
mmunofluorescence staining was not sensitive enough to
isualize filopodia in either WT or TG mice, and thus we
ere unable to determine whether the filopodial structures
ssociated with caniliculi were normal in TG osteocytes.
Ninety-day TG Females Have Increased Osteoclast
Staining on the Endocranial Surface of Calvaria
Between 35 and 90 days, the murine skeleton grows at a
much slower rate. Most bone formation during this period
contributes not to net skeletal growth, but to skeletal
turnover and remodeling. To determine whether the phe-
notype observed at 35 days persists during this later phase,
we analyzed the parietal bones of WT and TG animals at 90
days. The width of parietal bones of TG males at 90 days
was 84% that of WT males, compared with 45% that of WT
males at 35 days (Fig. 6B), suggesting that due to continued
slow growth and/or remodeling male animals were able to
repair or compensate for the original defect in matrix
deposition. In contrast, parietal bone width of 90-day TG
females was only 53% the value for WT females at 90 days.
Thus, the reduced bone width of transgenic females ob-
served at 35 days (Fig. 6B) persisted at 90 days.
During normal remodeling, bone formation by osteo-
blasts is tightly coupled to its resorption by osteoclasts, a
cell of hematopoietic origin that does not express osteocal-
cin. To determine whether transgene expression was indi-
rectly affecting bone resorption at this later time, calvaria
from 90-day TG animals were analyzed by whole-mount
staining for tartrate-resistant alkaline phosphatase activity,
which specifically stains osteoclasts in bone. In WT ani-
mals of both sexes and in TG males there was little staining
for TRAP at 90 days (Fig. 9). In contrast, TG females had
high levels of TRAP staining on the endocranial surface of
the parietal bone (Fig. 9), suggesting that there was an
increase in osteoclast number and/or activity on this sur-
face. At 35 days there had been very little staining for
osteoclasts on parietal bones of either sex in both WT and
TG animals (data not shown), and thus it is unlikely that
changes in osteoclast activity contributed to the decreased
bone mass observed in TG animals at 35 days. In contrast,
the findings at 90 days suggest that there is a second
phenotype in TG animals that is sex-specific and character-
ized by enhanced osteoclast activity on the inner surface of
the parietal bone in TG females.
s of reproduction in any form reserved.
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9Altered Integrin Function in OsteoblastsIncreased Resorption Results in a Net Loss of Bone
X-ray analysis was used to determine the density of bone
over the entire calvarial surface. In both 90-day WT and
FIG. 6. TG animals have thin parietal bones. (A) Cross sections t
male (c) and female (d) animals. The relative widths of the parieta
Quantitative measurements of the thickness of parietal bones fro
differences between WT and TG males and females are statistically
At 35 days, n 5 10 for TG females, 4 for TG males, 7 for WT fem
emales, 9 for TG males, and 6 for WT males.90-day TG females, areas of the parietal bone that had high o
Copyright © 2000 by Academic Press. All rightRAP staining also had decreased radiopacity (compare
igs. 10A and 10C to 10B and 10D). These data indicate that
n areas where TRAP staining was high, the resorption of
one by osteoclasts led to a net loss of bone mass. The
h the parietal bones of 35-day WT male (a) and female (b) and TG
es are indicated with arrows; note that WT male (a) is 100%. (B)
T and TG animals at 35 and 90 days. The bars denote SEM. The
ificant (for 35-day data P , 0.006; for 90-day data P , 0.05, t test).
and 5 for WT males. At 90 days, n 5 5 for TG females, 4 for WThroug
l bon
m W
signverall bone mass was much less in TG females compared
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10 Zimmerman et al.with WT females, which correlated with the increased
TRAP staining that we observed.
The matrix of bone undergoing resorption is distinct from
the matrix of quiescent or forming bone, and this difference
can be observed by scanning electron microscopy. Because
TRAP staining in TG females was particularly strong above
the occipital ridge (Fig. 10C), occipital bones were stripped
of cellular and other organic components and the structure
of the bone matrix was analyzed by scanning electron
microscopy (Fig. 11). In WT females the occipital ridge had
a smooth tapering surface (Fig. 11, black arrows, n 5 5). In
contrast, the occipital ridge in TG females was rough and
irregular (Fig. 11, white arrows, n 5 5), presumably due to
bone resorption by osteoclasts.
DISCUSSION
The osteoblast is a differentiated cell of mesenchymal
origin that produces and organizes most of the proteins
present in bone ECM. To better understand the function of
integrins in this unique cell type, we targeted expression of
a dominant-negative b1 integrin subunit, b1-DN, using
FIG. 7. In TG animals collagen fibrils are disorganized. (A) Cross
sections through WT and TG parietal bones viewed through
polarized light microscopy. Lamellar (LM) and woven (WO) bone
are indicated by arrows. (B) Quantitative measurements of the
organization of collagen fibrils in the parietal bone. The bars denote
SEM. The differences between WT (n 5 10) and TG (n 5 11) are
statistically significant (P , 0.6 3 1025).the osteocalcin promoter, which is expressed only in ma-
Copyright © 2000 by Academic Press. All rightture osteoblasts and osteocytes. b1-DN coded for a chimeric
olecule containing the cytoplasmic and transmembrane
omains of the b1 integrin subunit, with a truncated
ortion of the extracellular domain that terminates with an
-amino-acid epitope tag from HA. Based on our results, we
ropose that b1-DN expression affects bone metabolism by
t least two mechanisms, the first of which occurs when
he skeleton is rapidly growing. During this phase of bone
evelopment, interfering with integrin function leads to a
efect in the formation and organization of bone matrix.
oth sexes are affected by the defect initially. However,
ature male animals are eventually able to make a near
ormal amount of bone mass, once the period of rapid
rowth is completed, while mature females cannot. In-
reased resorption by osteoclasts in TG female mice, the
econd aspect of this phenotype involving altered integrin
unction, appears to render them incapable of fully compen-
ating for the original defect in bone formation.
FIG. 8. Osteoblast polarity and secretion of collagen I matrix are
altered in TG animals. Cross sections through the parietal bone of
35-day WT (A, C, and E) and TG (B, D, and F) animals stained by IF
with antibodies against Col I. (A and B) Most WT osteoblasts are
polarized, with the nucleus at the end away from the bone surface
(n, nucleus; c, cytoplasm; nuclei are stained by Hoechst). (C and D)
TG osteoblasts stain more strongly for intracellular Col I than WT:
note also altered cell polarization in TG. (E and F) The caniliculi of
osteocytes stain positively for Col I in WT (E) but not in TG (F)
samples (arrowheads). Similar differences were seen in preparations
stained for LN, FN, and osteopontin (not shown).
s of reproduction in any form reserved.
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11Altered Integrin Function in OsteoblastsOur results show that growing TG mice of both sexes had
decreased bone mass in cortical bone and in the flat bones of
the skull. At 35 days, the rate of bone formation in cortical
bone was decreased by 60%. Quantitative analysis of the
ECM associated with TG osteoblasts showed that active
osteoblasts had larger intracellular areas that stained
strongly by IF for matrix molecules such as Col I and LN.
Although not examined quantitatively, preliminary assess-
ment also suggested that TG osteoblasts were often nonpo-
lar. Taken together, the results shown in Fig. 8 suggest that
TG osteoblasts are defective in either the deposition or the
organization of matrix and that the defect in osteoblast
function may account for the observed decrease in the rate
of bone formation.
In TG animals, none of the matrix molecules that we
stained for by IF (including Col I, LN, FN, and osteocalcin)
stained canilicular structures around TG osteocytes, al-
though staining for these matrix components was very
strong in WT caniliculi (shown for Col I, Figs. 8E and 8F).
FIG. 9. TG females have increased staining for osteoclasts on the e
TG animals were fixed and stained for TRAP. The inner, or endoc
TG males, stained strongly for TRAP. The color photographs we
TRAP-stained bone appears white and unstained bone appears blaThese findings suggest that normal canilicular structures
Copyright © 2000 by Academic Press. All rightere not formed by osteocytes in TG animals. It is inter-
sting that b1-DN did not affect osteocyte lacunae forma-
tion or terminal differentiation. Further functional experi-
ments will be needed to determine what role, if any,
integrins have in these processes.
Using primary rat calvarial osteoblast cultures (Moursi et
al., 1996, 1997), and the 2T3 mouse osteoblast cell line
(Jikko et al., 1999), we showed previously that integrin
interactions with FN and Col I are critical for osteoblast
differentiation in vitro. In those experiments integrin–ECM
interactions were perturbed at early stages of osteoblast
differentiation, prior to the expression of osteocalcin. Os-
teocalcin is a tissue-specific marker for fully differentiated
osteoblasts and osteocytes (Mikuni-Takagaki et al., 1995),
and the promoter is not highly active in vivo until 1–2 days
before mineralization of the collagen matrix, which is after
the initial skeletal template has already been patterned and
formed (Ducy et al., 1997). Thus, by driving expression of
b1-DN with the osteocalcin promoter, we did not expect to
ranial surface of parietal bones. Parietal bones from 90-day WT and
l, surface of parietal bones from TG females, but not from WT or
nverted to gray scale and are shown as inverted images so thatndoc
rania
re cosee changes in skeletal patterning or osteoblast differentia-
s of reproduction in any form reserved.
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12 Zimmerman et al.tion because of transgene expression. Osteocalcin is also
more highly expressed in cortical bone than in trabecular
bone (G. Karsenty, personal communication), and in accor-
dance with this observation, we observed no difference in
bone volume or bone formation rate in trabecular bone (data
not shown). Future studies using constructs with
osteoblast-specific promoters expressed earlier in differen-
tiation will be needed to further elucidate the role of
integrins in skeletal patterning and trabecular bone forma-
tion.
Constructs similar to b1-DN have been used to perturb
ntegrin function in several different cell types in vitro
Chen et al., 1994; Faraldo et al., 1998; LaFlamme et al.,
FIG. 10. Areas on calvarial bones with increased TRAP staining h
ere fixed and stained for TRAP (left panels). X-ray analyses of the
f high TRAP staining are red and areas of decreased radiopacity a
FIG. 11. TG females show deterioration of the occipital ridge (OR
bones from females. Images were taken at 303 magnification.
Copyright © 2000 by Academic Press. All right1994; Lukashev et al., 1994; Smilenov et al., 1994). It has
thus been shown that b1-DN-type molecules affect differ-
nt integrin functions depending on the cell type and the
evels of expression (Lukashev et al., 1994). At relatively
ow levels of expression, b1-mediated signaling and matrix
organization are affected, whereas high levels of expression
of the transgene can cause cells to round up and detach. b1
ntegrin is highly expressed by osteoblasts (Gohel et al.,
995; Moursi et al., 1996), and high levels of b1-DN
expression are required to perturb endogenous b1 integrin
unction (Lukashev et al., 1994). In TG MSC cultures,
xpression of b1-DN was high enough to cause cell detach-
ment. However, we did not observe any evidence of cell
decreased bone mass. Calvarial bones from 90-day female animals
e bones are shown in mirror image (right panels). Note that areas
rk blue.
nning electron microscopy analysis of 90-day WT and TG occipitalave
sam). Scas of reproduction in any form reserved.
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13Altered Integrin Function in Osteoblastsdetachment in vivo, possibly because of the more complex
nature of the ECM or because firmer cell adhesion to this
ECM in vivo makes cell attachment more difficult to
perturb.
Our results are consistent with findings from other sys-
tems about the in vivo roles of integrins in tissue formation
and organization. b1 deficiency in F9 teratocarcinomas
nterferes with cell polarity and basement membrane as-
embly and results in changes in the composition of the
asement membrane (Sasaki et al., 1998; Stephens et al.,
993). Recently, a chimeric molecule similar to b1-DN,
ontaining the cytoplasmic and transmembrane domains of
he b1-integrin chain and the extracellular domain of the
-cell differentiation antigen CD4, was targeted to the
ouse mammary gland by the mouse mammary tumor
irus MMTV promoter (Faraldo et al., 1998). Targeting of
his dominant-negative integrin chain interfered with nor-
al mammary gland development and function. In these
G mice, there were changes in the distribution of LN and
b4 integrin from strictly basal to basal and lateral. Here we
have shown, using a similar approach, that integrins are
directly involved in multiple osteoblast functions, includ-
ing maintaining cell polarity and regulating the deposition
of bone matrix and the formation and/or composition of
osteocyte caniliculi (Fig. 12).
In mature animals normal bone mass is maintained by
the remodeling of existing bone structures and involves a
delicate balance between the activities of bone-forming
osteoblasts and matrix-degrading osteoclasts. Increased
bone remodeling caused by physiological or environmental
factors often results in a net loss of bone (Teitelbaum et al.,
1997). In mature (90-day) TG females, we observed an
increase in osteoclast staining on the endocranial surface of
the parietal bone. The areas of the parietal and occipital
bones that showed increased staining also corresponded to
areas of decreased bone mass. These findings suggest that
the decrease in bone mass observed in 90-day TG females
was due to increased resorptive activity by osteoclasts,
rather than to a continuation of the original defect in matrix
deposition.
TG males did not have increased staining for osteoclasts
at 90 days, and the width of the parietal bones was similar
to that of WT males. This result suggests that in males, the
primary defect in matrix deposition observed at the conclu-
sion of the rapid growth phase (35 days) was compensated
for over the period of slow growth and onset of remodeling.
At both 35 and 90 days there is no sex difference in
expression from the osteocalcin promoter in vivo (Frenkel
t al., 1997). Thus, the sex differences we observe in the
ater phenotype (90 days) are most likely due to direct
ffects of b1-DN expression. As a result, mature females
have a decrease in bone mass that results, at least in part,
from increased bone resorption by osteoclasts. This finding
suggests that integrins might be involved in osteocyte
signaling and raises the question of whether integrin signal-
ing through osteoblasts or osteocytes is involved in hor-
monal regulation of bone remodeling.
Copyright © 2000 by Academic Press. All rightOsteoblasts have multiple complex interactions with
ECM that change as an osteoblast differentiates into an
osteocyte (Fig. 12). Here we have shown that integrins are
required at multiple stages of osteoblast function and that
altering integrin function in mature osteoblasts in vivo
causes changes in osteoblast function that lead to decreased
bone mass by at least two different mechanisms.
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